Johnson & Johnson Price to Book Ratio 2010-2024 | JNJ

Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of April 22, 2024 is 5.22.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Johnson & Johnson Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-04-23 149.56 5.23
2023-12-31 155.56 $28.57 5.44
2023-09-30 153.36 $29.59 5.18
2023-06-30 161.82 $29.41 5.50
2023-03-31 150.39 $27.27 5.51
2022-12-31 170.20 $29.39 5.79
2022-09-30 156.39 $28.51 5.49
2022-06-30 168.80 $29.04 5.81
2022-03-31 167.48 $28.41 5.89
2021-12-31 160.62 $28.16 5.70
2021-09-30 150.63 $26.69 5.64
2021-03-31 151.44 $25.01 6.06
2020-12-31 144.12 $24.04 6.00
2020-09-30 135.38 $24.49 5.53
2020-06-30 127.04 $23.92 5.31
2020-03-31 117.63 $23.28 5.05
2019-12-31 130.01 $22.59 5.75
2019-09-30 114.52 $22.13 5.18
2019-06-30 123.28 $23.01 5.36
2019-03-31 122.89 $22.20 5.54
2018-12-31 112.71 $22.44 5.02
2021-06-30 152.74 $26.44 5.78
2018-09-30 119.91 $24.09 4.98
2018-06-30 104.60 $23.45 4.46
2018-03-31 109.66 $23.58 4.65
2017-12-31 118.81 $22.43 5.30
2017-09-30 109.88 $27.55 3.99
2017-06-30 111.10 $26.78 4.15
2017-03-31 103.92 $26.10 3.98
2016-12-31 95.50 $26.02 3.67
2016-09-30 97.25 $26.73 3.64
2016-06-30 99.20 $26.47 3.75
2016-03-31 87.86 $26.40 3.33
2015-12-31 82.81 $25.82 3.21
2015-09-30 74.71 $25.86 2.89
2015-06-30 77.39 $25.69 3.01
2015-03-31 79.31 $24.45 3.24
2014-12-31 81.86 $25.06 3.27
2014-09-30 82.91 $27.31 3.04
2014-06-30 80.83 $27.65 2.92
2014-03-31 75.37 $27.08 2.78
2013-12-31 69.77 $26.25 2.66
2013-09-30 65.58 $24.75 2.65
2013-06-30 64.47 $24.75 2.60
2013-03-31 60.76 $23.85 2.55
2012-12-31 51.83 $23.33 2.22
2012-09-30 50.51 $23.08 2.19
2012-06-30 49.07 $21.97 2.23
2012-03-31 47.45 $22.35 2.12
2011-12-31 46.77 $20.95 2.23
2011-09-30 45.00 $22.52 2.00
2011-06-30 46.59 $22.67 2.05
2011-03-31 41.14 $21.86 1.88
2010-12-31 42.56 $20.66 2.06
2010-09-30 42.27 $20.85 2.03
2010-06-30 39.91 $19.19 2.08
2010-03-31 43.66 $19.19 2.28
2009-12-31 42.81 $18.37 2.33
2009-09-30 40.15 $18.27 2.20
2009-06-30 37.16 $16.79 2.21
2009-03-31 34.10 $15.87 2.15
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $359.347B $85.159B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $694.884B 115.72
Novo Nordisk (NVO) Denmark $562.108B 46.31
Merck (MRK) United States $321.543B 84.63
AbbVie (ABBV) United States $297.274B 15.11
AstraZeneca (AZN) United Kingdom $217.434B 19.27
Novartis AG (NVS) Switzerland $194.425B 13.97
Pfizer (PFE) United States $148.698B 14.35
Sanofi (SNY) $119.271B 10.74
Innoviva (INVA) United States $0.944B 6.67